Generex Biotechnology Corporation's Synthetic Vaccine Platform Represented At International Swine Flu Conference
August 27, 2009 08:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 27, 2009 (GLOBE NEWSWIRE) -- The synthetic vaccine platform technology of Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) was featured last week at the first...
Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine
August 24, 2009 14:24 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 24, 2009 (GLOBE NEWSWIRE) -- Anna E. Gluskin, the chairman, president and CEO of Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), was featured this morning on...
Generex Announces Sales Agreement With McCarthy and Sons Service
August 18, 2009 08:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 18, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Raises $5.65 Million in a Registered Direct Offering of Common Stock
August 06, 2009 16:05 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza
August 05, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 5, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced publication of pre-clinical studies conducted to identify vaccine...
Amgen Co-founder to Act as Generex Chief Scientific Advisor
August 04, 2009 10:15 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Reports Annual Meeting Resulted in Shareholders Passing All Proxy Proposals With Strong Support
August 03, 2009 09:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Announces Plans to File An Investigational New Drug (IND) With the Veterinary Drugs Directorate of Health Canada in Anticipation of a New Drug Submission for Generex Oral-lyn(tm)
July 22, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 22, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine for HPV-Induced Cervical Cancer
July 20, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 20, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today publication of studies demonstrating the anti-cancer activity of a...
Generex Sees Favorable Results From MetControl(tm) Chewing Gum Bio-equivalency Study Leading to Global Product Submissions
June 29, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 29, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...